Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

306JPY
22 Jun 2018
Change (% chg)

¥-2 (-0.65%)
Prev Close
¥308
Open
¥306
Day's High
¥309
Day's Low
¥304
Volume
651,300
Avg. Vol
2,065,138
52-wk High
¥510
52-wk Low
¥287

Summary

Name Age Since Current Position

Yoshihiro Arai

47 2013 President, Representative Director

Toshio Miyashita

50 2015 Chief Financial Officer, Chief Director of Administration, Director

Norikazu Eiki

70 2016 Independent Director

Tajio Enoki

51 2018 Independent Director

Stanley Lau

63 2014 Independent Director

Masahiro Michisuji

82 2008 Independent Director

Yasumitsu Shimada

2017 Director of Accounting

Biographies

Name Description

Yoshihiro Arai

Mr. Yoshihiro Arai has been serving as President and Representative Director in Solasia Pharma K.K. since February 2013. He joined the former entity of the Company in September 2007. He previously served as Chief Director of Development in the Company. He used to work for Pfizer Japan Inc. and Amgen Inc.

Toshio Miyashita

Mr. Toshio Miyashita has been serving as Chief Financial Officer, Chief Director of Administration and Director in Solasia Pharma K.K. since December 2015. He joined the Company in January 2014. He used to work for other eight companies, including INNOTECH CORPORATION, Sosei Group Corporation, Arakis Limited, HIBIKI Partners Co., Ltd., ATANI LIMITED and J-Pharma Co., Ltd.

Norikazu Eiki

Mr. Norikazu Eiki has been serving as Independent Director in Solasia Pharma K.K. since April 2016. He is also serving as Independent Director in AnGes, Inc., Towa Pharmaceutical Co., Ltd. and FunPep Co., Ltd. He used to work for Panasonic Corporation, Novartis Pharma K.K. and Bayer Yakuhin Ltd.

Tajio Enoki

Mr. Tajio Enoki has been serving as Independent Director in Solasia Pharma K.K. since March 30, 2018. He is also serving as Vice Chairman of the Board in BEIJING ITOCHU-HUATANG COMPREHENSIVE PROCESSING CO., LTD., as well as Deputy General Manager in PTAGENT CORPORATION. He is also working for ITOCHU Shanghai Commercial Affairs Co., Ltd. He used to work for an affiliated company, ITOCHU Corporation, and JAPAN PHARMACEUTICALS AND COSMETICS (CHINA) CO., LTD.

Stanley Lau

Mr. Stanley Lau has been serving as Independent Director in Solasia Pharma K.K. since December 2014. He is also serving as Independent Director in Xian Libang Pharmaceutical, Executive Partner in BizPro International LLC, as well as Senior Adviser in Wuxi SiFong Information Technology Co., Ltd. He used to work for Pfizer Corp. Hong Kong, Merck & Co., Schering Plough China Ltd., Pharmacia / Searle Asia, Baxter Healthcare International China, Haopy Pharmaceuticals Co., Ltd., China Biologic Products, Inc., Eddingpharm Ltd. and Amsino Medical Group.

Masahiro Michisuji

Mr. Masahiro Michisuji has been serving as Independent Director in Solasia Pharma K.K. since April 2008. He used to work for other seven companies, including MSD K.K., Pfizer Japan Inc., Bristol-Myers Squibb, Novartis Pharma K.K., Novartis International AG and Johnson Company, Limited.

Yasumitsu Shimada